Abstract
To develop a health economic budget impact model estimating the direct medical cost savings and bed day capacity release when replacing a non-antimicrobial intravascular (IV) catheter site dressing with an antimicrobial, chlorhexidine containing IV catheter securement dressing in patients receiving haemodialysis (HD) via tunnelled central venous catheter (CVC).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
